Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥8,068 | CN¥1,903 | CN¥2,143 | CN¥1,666 |
| - Cash | CN¥668 | CN¥540 | CN¥418 | CN¥294 |
| + Debt | CN¥533 | CN¥150 | CN¥129 | CN¥339 |
| Enterprise Value | CN¥7,932 | CN¥1,513 | CN¥1,854 | CN¥1,710 |
| Revenue | CN¥1,312 | CN¥1,066 | CN¥1,257 | CN¥1,006 |
| % Growth | 23.1% | -15.2% | 24.9% | – |
| Gross Profit | CN¥574 | CN¥545 | CN¥641 | CN¥450 |
| % Margin | 43.8% | 51.1% | 51% | 44.7% |
| EBITDA | CN¥464 | CN¥440 | CN¥517 | CN¥353 |
| % Margin | 35.3% | 41.3% | 41.1% | 35.1% |
| Net Income | CN¥345 | CN¥328 | CN¥403 | CN¥250 |
| % Margin | 26.3% | 30.8% | 32% | 24.9% |
| EPS Diluted | 0.68 | 0.93 | 1.2 | 0.71 |
| % Growth | -26.9% | -22.5% | 69% | – |
| Operating Cash Flow | CN¥163 | CN¥390 | CN¥480 | CN¥142 |
| Capital Expenditures | -CN¥75 | -CN¥67 | -CN¥134 | -CN¥192 |
| Free Cash Flow | CN¥88 | CN¥322 | CN¥346 | -CN¥50 |